Literature DB >> 21119720

Hearing shines spotlight on biosimilar controversies.

Asher Mullard.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21119720     DOI： 10.1038/nrd3325

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

Review 1.  Subsequent entry biologics/biosimilars: a viewpoint from Canada.

Authors:  Anthony S Russell; Vandana Ahluwalla; Cheryl Barnabe; Shahin Jamal; Robert C Offer; Wojciech P Olszynski; Kam Shojania; Boulos Haraoui
Journal:  Clin Rheumatol       Date:  2012-08-26       Impact factor: 2.980

2.  Biosimilars: the debate continues.

Authors:  Robert A Colbert; Bruce N Cronstein
Journal:  Arthritis Rheum       Date:  2011-10

3.  Biosimilar, biobetter and next generation therapeutic antibodies.

Authors:  Alain Beck
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.